Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_assertion type Assertion NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_head.
- NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_assertion description "[The gain of function of miR-93/106b in leiomyoma smooth muscle cells, myometrial smooth muscle cells, and the leiomyosarcoma cell line dose dependently repressed F3 and IL8 through direct interactions with their respective 3'-untranslated region and indirectly through F3 repression inhibited IL8, CTGF, and PAI-1 expression, confirmed by using small interfering RNA silencing or factor Vlla (FVIIa) activation of F3, as well as reducing the rate of proliferation, while increasing caspase-3/7 activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_provenance.
- NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_assertion evidence source_evidence_literature NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_provenance.
- NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_assertion SIO_000772 22556343 NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_provenance.
- NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_assertion wasDerivedFrom befree-20150227 NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_provenance.
- NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_assertion wasGeneratedBy ECO_0000203 NP606929.RAD6p2imN4xUg_1qGxfw5liPE3zrNAyCxjjAsQprdEnHU130_provenance.